ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 660029 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 660029; 2) Community: the network communities that were significantly associated with the response to NSC 660029; 3) Molecule: the relationships between components within communities and NSC 660029; 4) MDR: the compounds that were significantly associated with the NSC 660029.

NSC Compound Enrichment Correlation
NSC 47468 Null 0.022188614181866 0.35076868
NSC 52426 Null 0.022188614181866 0.21871401
NSC 603071 Aminocamptothecin 0.022188614181866 0.39958551
NSC 603578 Platinum, tetrachloro[dimethylsilylenebis(methanamine)]-, (OC-6-22) 0.022188614181866 0.4981001
NSC 606497 Camptothecin Derivative 0.022188614181866 0.47776735
NSC 624657 ANTINEOPLASTIC-624657 0.022188614181866 -0.12434776
NSC 676466 Null 0.022188614181866 0.18720652
NSC 679006 2-Butenedioic acid, 2,2'-(5-methyl-2,4-dioxopyrimidine- 1,3-diyl)bis-, tetraethyl ester 0.022188614181866 0.078638288
NSC 681641 Camptothecin Derivative 0.022188614181866 0.30159893
NSC 683833 Null 0.022188614181866 0.055171851
Total:69  Current:36    [First] [Prev] [Next] [Last]